Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2024 earnings per ...

Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of ...

Leerink Partners analyst Mike Kratky maintained a Hold rating on Edwards Lifesciences (EW – Research Report) on November 25 and set a price ...

Analysts at Leerink Partnrs upped their FY2026 EPS estimates for shares of Edwards Lifesciences in a research note issued to ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Edwards Lifesciences' estimated fair value is US$69.12 based on 2 Stage Free Cash Flow to Equity Edwards Lifesciences' US$71.27 share price indicates it is trading at similar levels as its fair value ...

RBC Capital raised the firm’s price target on Edwards Lifesciences (EW) to $80 from $75 and keeps an Outperform rating on the shares. The firm ...

EW LEGAL UPDATE: A Lawsuit Has Been Filed Against Edwards Lifesciences For Securities Fraud - Contact BFA Law Before Court Deadline (NYSE:EW) ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 ...

EW STOCK REPORT: Suffer Losses On Your Edwards Lifesciences Investment? Contact BFA Law About The Pending Class Action Lawsuit (NYSE:EW) ...